VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs

ConferenceNAMkind™Positive

AI Analysis

Summary

VivoSim Labs presented new NAMkind™ drug toxicity data at EUROTOX 2026 in Vienna, demonstrating predictive capabilities for liver and gastrointestinal safety assessment across small molecules and antibody-drug conjugates.

Outcome Details

Data presentation on drug toxicity predictive modeling for liver and gastrointestinal safety

Importance:4/10

Sentiment:

0.60

drug toxicitysafety assessmentADCssmall moleculespredictive modelingGI barrierliver safetyEUROTOX 2026Vienna

Related Companies

$POAI

Read the original article

Published by GlobeNewswire Clinical Studies on September 16, 2026 12:05 PM

Read Original